This website is intended for international healthcare professionals with an interest in the treatment of Nocturia. By clicking the link below you are declaring and confirming that you are a healthcare professional. Please answer a few short questions about this resource centre.

You are here

NOPIA Autumn School

Message from Professor Karel Everaert:


During the last 5 years a tremendous amount of new literature has been published on nocturia and nocturnal polyuria and we aim at summarizing these new insights and presenting them to you in a practical way so that you can use this information in your clinical approach.

Nocturia, a symptom and a disease

Initially, nocturia was seen as a symptom, later as a bothersome symptom and lately as a bothersome symptom that needs to be diagnosed, because sleep disruption is a serious health issue and because nocturia can be the consequence of serious underlying disease (comparable to erectile dysfunction).

Nocturia related physiology for the Urologist

Nocturnal polyuria and polyuria are the main causes of nocturia. Urine productions has a complicated physiology and is at first sight far away from what urologists are dealing with. Basic and comprehensible insights in this physiology and physiopathology increase our knowledge and help us to treat our patients better.

Diagnosing nocturia, hands on

When diagnosing nocturia we need to understand the cause of this symptom. We typically need to screen our patients for a reduced bladder capacity, nocturnal polyuria and polyuria and sleep disorders. The frequency volume chart, the renal function profile and questionnaires to screen sleep pathology are helpful tools. Reality shows that we do not use these tools enough in our clinical practice.

Treating nocturia, hands on

How does nocturia treatment fit into the EAU guidelines? Are there conservative measures to be taken and what is their evidence? Clinicians tend to treat nocturia with furosemide believing it to be a safe drug for this indication. Furosemide has exactly the same side effects and risks as desmopressin but clinicians do not realise this. Furthermore, furosemide has very weak evidence of efficacy and the available efficacy is only short-term evidence whereas there is strong and long-term evidence of efficacy for desmopressin.

We look forward to meeting you in the beautiful medieval city of Ghent!

Prof Dr Karel Everaert


If you wish to register, please send an email to Sue@eventsco.com – places are limited and will be allocated on a first come first served basis.

Nov 2015

Address details


Location information

NH Hotel Belfort